EMEA-001428-PIP01-13

Key facts

Active substance
Esketamine
Therapeutic area
Psychiatry
Decision number
P/0177/2013
PIP number
EMEA-001428-PIP01-13
Pharmaceutical form(s)
  • Nasal spray
  • solution
Condition(s) / indication(s)
Treatment of major depressive disorder
Route(s) of administration
Intranasal use
Contact for public enquiries
Janssen-Cilag International N.V. 
Belgium 
E-mail: mojanen@ITS.JNJ.com
Tel. +34 917228079
Decision type
RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s)

Decision

How useful was this page?

Add your rating
Average
2 ratings